Easy Bright Pharmaceuticals Co., Ltd.

Notice on the Listing and Circulation of Shares Released from the First Lock-up Period of the 2024 Restricted Stock Incentive Plan

Legal Opinion from Beijing Zhide Law Firm on the 2025 Annual Shareholders' Meeting of Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd.

Announcement of the 2025 Annual Shareholders' Meeting Resolutions

Announcement on Holding the 2025 Annual Performance Briefing

Pre-disclosure Announcement on Share Reduction by Shareholders Holding More Than 5%

Announcement on the Renewal of the Accounting Firm for 2026

2025 Annual Financial Settlement Report

Announcement on Authorizing the Board to Formulate a Mid-term Dividend Plan

Announcement on the Confirmation of 2025 Annual Compensation for Directors and Senior Management and the 2026 Compensation Plan

2025 Independent Director's Work Report (Wang Guangying)

2025 Independent Director's Work Report (Feng Lan - Resigned)

2025 Independent Director's Work Report (Hu Ming - Resigned)

2025 Independent Director's Work Report (Xiao Xinggang - Resigned)

2025 Independent Director's Work Report (Chen Yan)

2025 Independent Director's Work Report (He Deming)

2025 Annual Internal Control Audit Report

2025 Annual Internal Control Evaluation Report

Legal Opinion from Beijing Zhide Law Firm on the First Grant and Reserved Grant Conditions Achievement of the 2024 Restricted Stock Incentive Plan of Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd.

Verification Opinion of the Board's Compensation and Assessment Committee on the First Grant and Reserved Grant Conditions Achievement of the 2024 Restricted Stock Incentive Plan

Announcement on the First Grant and Reserved Grant Conditions Achievement of the 2024 Restricted Stock Incentive Plan

Announcement on the Re-election of Some Non-Independent Directors of the Company

Special Audit Report on the Achievement of Performance Commitments by the Original Actual Controller

Announcement on the Implementation of Excess Performance Rewards and Related Transactions

Notice of the 2025 Annual Shareholders' Meeting

Announcement of Resolutions of the 6th Meeting of the 4th Board of Directors

Announcement on the Profit Distribution Plan for 2025

2026 Q1 Report

Announcement on the Evaluation Report of the Accounting Firm's Performance in 2025

Audit Committee Report on the Performance of Supervisory Responsibilities by the Accounting Firm in 2025

Special Report on Non-Operating Fund Occupation and Other Related Fund Transactions in 2025